AlpInvest Partners B.V. lowered its position in shares of 10x Genomics, Inc. (NASDAQ:TXG – Get Rating) by 24.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 7,819 shares of the company’s stock after selling 2,552 shares during the period. 10x Genomics […]
Hamilton Lane Advisors LLC boosted its stake in shares of 10x Genomics, Inc. (NASDAQ:TXG – Get Rating) by 241.1% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 26,410 shares of the company’s stock after purchasing an additional 18,667 shares during the period. Hamilton Lane Advisors […]
Barclays initiated coverage on shares of 10x Genomics (NASDAQ:TXG – Get Rating) in a research report report published on Wednesday morning, The Fly reports. The firm issued an overweight rating and a $65.00 price objective on the stock. A number of other research analysts also recently commented on TXG. Cowen increased their price objective on […]
Abundance Wealth Counselors bought a new position in 10x Genomics, Inc. (NASDAQ:TXG – Get Rating) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 6,443 shares of the company’s stock, valued at approximately $235,000. Several other hedge funds have also modified their […]
10x Genomics (NASDAQ:TXG – Get Rating) announced its quarterly earnings data on Wednesday. The company reported ($0.44) earnings per share for the quarter, missing the consensus estimate of ($0.38) by ($0.06), Briefing.com reports. 10x Genomics had a negative return on equity of 20.93% and a negative net margin of 32.15%. The firm had revenue of […]